Cardiology

Episodes 33-48 of 74

• 

  RestartResume

  Revascularization Therapy:  Who, How & When?

  RestartResume

  Revascularization Therapy:  Who, How & When?

  MinuteCE®

  Revascularization Therapy:  Who, How & When?

  1.00 program credit

  • 

    

    Alik Farber, MD, MBA, FACS, DFSVS

  • 

    

    Connie N. Hess, MD, MHS

  1.00 program credit

• 

  RestartResume

  PAD Stage, Risk Assessment & Comorbidities

  RestartResume

  PAD Stage, Risk Assessment & Comorbidities

  MinuteCE®

  PAD Stage, Risk Assessment & Comorbidities

  1.00 program credit

  • 

    

    Connie N. Hess, MD, MHS

  1.00 program credit

• 

  MinuteCE®

  Guidelines on the Management of Patients with PAD

  1.00 credit 9 episodes

  • 

    

    Marc P. Bonaca, MD, MPH

  • 

    

    Alik Farber, MD, MBA, FACS, DFSVS

  • 

    

    Naomi Hamburg, MD, MS

  • 

    

    Connie N. Hess, MD, MHS

  • 

    

    Schuyler Jones, MD

  • 

    

    Manesh R. Patel, MD

  1.00 credit 9 episodes

• 

  RestartResume

  Medical Therapy: New Horizons of Diabetic Therapies

  RestartResume

  Medical Therapy: New Horizons of Diabetic Therapies

  MinuteCE®

  Medical Therapy: New Horizons of Diabetic Therapies

  1.00 program credit

  • 

    

    Naomi Hamburg, MD, MS

  1.00 program credit

• 

  RestartResume

  Overcoming Disparities of Care - Impact of Social Determinants of Health of PAD

  RestartResume

  Overcoming Disparities of Care - Impact of Social Determinants of Health of PAD

  MinuteCE®

  Overcoming Disparities of Care - Impact of Social Determinants of Health of PAD

  1.00 program credit

  • 

    

    Schuyler Jones, MD

  1.00 program credit

• 

  RestartResume

  Medical Therapy: Lipid Modifying Therapies

  RestartResume

  Medical Therapy: Lipid Modifying Therapies

  MinuteCE®

  Medical Therapy: Lipid Modifying Therapies

  1.00 program credit

  • 

    

    Schuyler Jones, MD

  1.00 program credit

• 

  RestartResume

  Medical Therapy: Antithrombotic Management of PAD—What Has Changed?

  RestartResume

  Medical Therapy: Antithrombotic Management of PAD—What Has Changed?

  MinuteCE®

  Medical Therapy: Antithrombotic Management of PAD—What Has Changed?

  1.00 program credit

  • 

    

    Marc P. Bonaca, MD, MPH

  • 

    

    Manesh R. Patel, MD

  1.00 program credit

• 

  RestartResume

  Are the current guidelines current?

  RestartResume

  Are the current guidelines current?

  MinuteCE®

  Are the current guidelines current?

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  1.00 program credit

• 

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  RestartResume

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  MinuteCE®

  Risk and How Risk Directs Treatment: Challenges and Barriers to Risk Stratification

  1.00 program credit

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  RestartResume

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  MinuteCE®

  Risk Stratification Refinements with inclusion of Hemodynamic variables at follow up in patients with PH  

  1.00 program credit

  • 

    

    Richard N. Channick, MD

  1.00 program credit

• 

  MinuteCE®

  The Next Generation of Treatment for Patients With PH

  1.00 credit 4 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 credit 4 episodes

• 

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  RestartResume

  Strategies to Implement Risk Stratification in the PH Clinic

  MinuteCE®

  Strategies to Implement Risk Stratification in the PH Clinic

  1.00 program credit

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  1.00 program credit

• 

  RestartResume

  The Promise of Sotatercept in PAH

  RestartResume

  The Promise of Sotatercept in PAH

  MinuteCE®

  The Promise of Sotatercept in PAH

  1.50 program credits

  • 

    

    Ioana Preston, MD

  1.50 program credits

• 

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  RestartResume

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  MinuteCE®

  Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension

  1.50 program credits

  • 

    

    Vallerie V. McLaughlin, MD

  1.50 program credits

• 

  MinuteCE®

  Integrating Evidence for Improved Outcomes in PH

  1.50 credits 6 episodes

  • 

    

    Richard N. Channick, MD

  • 

    

    Vallerie V. McLaughlin, MD

  • 

    

    Ioana Preston, MD

  • 

    

    Kelly Chin, MD, MSCA

  • 

    

    Richard Krasuski, MD

  1.50 credits 6 episodes

• 

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  RestartResume

  Update in Pediatric Pulmonary Hypertension

  MinuteCE®

  Update in Pediatric Pulmonary Hypertension

  1.50 program credits

  • 

    

    Richard Krasuski, MD

  1.50 program credits